nebiten 5 mg tabletes
g.l. pharma gmbh, austria - nebivolols - tabletes - 5 mg
nebivolol krka 5 mg tabletes
krka, d.d., novo mesto, slovenia - nebivolols - tablete - 5 mg
zydelig
gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.
rapamune
pfizer europe ma eeig - sirolims - graft rejection; kidney transplantation - imūnsupresanti - rapamune ir indicēts orgānu atgrūšanas profilaksei pieaugušiem pacientiem ar zemu vai vidēji smagu imunoloģisku risku, ka tiek saņemta nieru transplantācija. tas ir ieteicams, ka rapamune izmantot sākotnēji kopā ar ciclosporin microemulsion un kortikosteroīdi 2 līdz 3 mēneši. rapamune var turpināt, jo apkopes terapija ar kortikosteroīdiem tikai tad, ja ciclosporin microemulsion var pakāpeniski pārtraukta. rapamune ir indicēts, lai ārstētu pacientus ar sporādisku lymphangioleiomyomatosis ar vidēji smagu plaušu slimību vai samazinās plaušu funkciju.
darunavir sandoz 75 mg apvalkotās tabletes
sandoz d.d., slovenia - darunavīrs - apvalkotā tablete - 75 mg
darunavir sandoz 800 mg apvalkotās tabletes
sandoz d.d., slovenia - darunavīrs - apvalkotā tablete - 800 mg
darunavir sandoz 400 mg apvalkotās tabletes
sandoz d.d., slovenia - darunavīrs - apvalkotā tablete - 400 mg
darunavir sandoz 600 mg apvalkotās tabletes
sandoz d.d., slovenia - darunavīrs - apvalkotā tablete - 600 mg
certican 0,25 mg tabletes
novartis baltics, sia, latvia - everolims - tablete - 0,25 mg
certican 0,5 mg tabletes
novartis baltics, sia, latvia - everolims - tablete - 0,5 mg